PUBLISHER: TechNavio | PRODUCT CODE: 2126226
PUBLISHER: TechNavio | PRODUCT CODE: 2126226
Global IVD Reagents Market 2026-2030
The global IVD reagents market is forecasted to grow by USD 18439.9 mn during 2025-2030, accelerating at a CAGR of 6.5% during the forecast period. The report on the global IVD reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating global burden of chronic and infectious diseases , technological breakthroughs in molecular diagnostics and next-generation sequencing platforms, accelerating transition toward decentralized care models and point-of-care diagnostic testing.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 6.1% |
| CAGR | 6.5% |
| Incremental Value | $18439.9 mn |
Technavio's global IVD reagents market is segmented as below:
By Type
- Immunoassay reagents
- Clinical chemistry reagents
- Molecular diagnostic reagents
- Hematology and coagulation reagents
- Microbiology reagents
By End-User
- Hospitals and clinics
- Diagnostic laboratories
- IVD manufacturers
- Academic and research institutes
- Blood banks and transfusion centers
By Application
- Infectious disease testing
- Oncology testing
- Cardiovascular disease testing
- Diabetes and metabolic testing
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Russia
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the integration of ai and advanced data analytics in laboratory workflows as one of the prime reasons driving the global ivd reagents market growth during the next few years. Also, expanding utilization of biomarker-driven companion diagnostics in precision medicine and consolidation and automation of core laboratory infrastructure will lead to sizable demand in the market.
The report on the global ivd reagents market covers the following areas:
- Global ivd reagents market sizing
- Global ivd reagents market forecast
- Global ivd reagents market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global ivd reagents market vendors that include Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Canvax, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Otto Chemie Pvt. Ltd., QuidelOrtho Corp., REKOM BIOTECH S.L., Revvity Inc., Ricca Chemical Co., Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., Tokyo Chemical Industry Co., Tosoh Bioscience, Tulip Diagnostics Pvt. Ltd., Werfenlife SA. Also, the global ivd reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global IVD Reagents Market 2020 - 2024
- Historic Market Size - Data Table on Global IVD Reagents Market 2020 - 2024 ($ million)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global IVD Reagents Market
- 6.2 Impact of Geopolitical Conflicts on Global IVD Reagents Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Type
- 8.1 Market segments
- 8.2 Comparison by Type
- 8.3 Immunoassay reagents - Market size and forecast 2025-2030
- 8.4 Clinical chemistry reagents - Market size and forecast 2025-2030
- 8.5 Molecular diagnostic reagents - Market size and forecast 2025-2030
- 8.6 Hematology and coagulation reagents - Market size and forecast 2025-2030
- 8.7 Microbiology reagents - Market size and forecast 2025-2030
- 8.8 Market opportunity by Type
- Market opportunity by Type ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Hospitals and clinics - Market size and forecast 2025-2030
- 9.4 Diagnostic laboratories - Market size and forecast 2025-2030
- 9.5 IVD manufacturers - Market size and forecast 2025-2030
- 9.6 Academic and research institutes - Market size and forecast 2025-2030
- 9.7 Blood banks and transfusion centers - Market size and forecast 2025-2030
- 9.8 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Application
- 10.1 Market segments
- 10.2 Comparison by Application
- 10.3 Infectious disease testing - Market size and forecast 2025-2030
- 10.4 Oncology testing - Market size and forecast 2025-2030
- 10.5 Cardiovascular disease testing - Market size and forecast 2025-2030
- 10.6 Diabetes and metabolic testing - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Application
- Market opportunity by Application ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.4.7 Russia - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.5.7 Singapore - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Australia - Market size and forecast 2025-2030
- 12.6.3 South Africa - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.6 UAE - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Escalating global burden of chronic and infectious diseases
- Technological breakthroughs in molecular diagnostics and next-generation sequencing platforms
- Accelerating transition toward decentralized care models and point-of-care diagnostic testing
- 13.2 Market challenges
- Complex regulatory frameworks and stringent compliance requirements
- High capital infrastructure costs and shortage of skilled laboratory personnel
- Restrictive reimbursement frameworks and inadequate coverage policies
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration of AI and advanced data analytics in laboratory workflows
- Expanding utilization of biomarker-driven companion diagnostics in precision medicine
- Consolidation and automation of core laboratory infrastructure
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
- 15.6 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.7 BioMerieux SA
- BioMerieux SA - Overview
- BioMerieux SA - Business segments
- BioMerieux SA - Key offerings
- BioMerieux SA - Segment focus
- SWOT
- 15.8 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- SWOT
- 15.9 DiaSorin SpA
- DiaSorin SpA - Overview
- DiaSorin SpA - Business segments
- DiaSorin SpA - Key news
- DiaSorin SpA - Key offerings
- DiaSorin SpA - Segment focus
- SWOT
- 15.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.11 QuidelOrtho Corp.
- QuidelOrtho Corp. - Overview
- QuidelOrtho Corp. - Business segments
- QuidelOrtho Corp. - Key offerings
- QuidelOrtho Corp. - Segment focus
- SWOT
- 15.12 Revvity Inc.
- Revvity Inc. - Overview
- Revvity Inc. - Business segments
- Revvity Inc. - Key offerings
- Revvity Inc. - Segment focus
- SWOT
- 15.13 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 15.14 Sysmex Corp.
- Sysmex Corp. - Overview
- Sysmex Corp. - Business segments
- Sysmex Corp. - Key news
- Sysmex Corp. - Key offerings
- Sysmex Corp. - Segment focus
- SWOT
- 15.15 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.16 Tosoh Bioscience
- Tosoh Bioscience - Overview
- Tosoh Bioscience - Product / Service
- Tosoh Bioscience - Key offerings
- SWOT
- 15.17 Tulip Diagnostics Pvt. Ltd.
- Tulip Diagnostics Pvt. Ltd. - Overview
- Tulip Diagnostics Pvt. Ltd. - Product / Service
- Tulip Diagnostics Pvt. Ltd. - Key offerings
- SWOT
- 15.18 Werfenlife SA
- Werfenlife SA - Overview
- Werfenlife SA - Product / Service
- Werfenlife SA - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
